Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
177Lu-FC705 belongs to the 2nd generation of albumin binders introduced drugs. Its hydrophilicity is higher than that of other compounds, and has low nonspecific binding.
Lead Product(s): [177Lu]Ludotadipep
Therapeutic Area: Oncology Product Name: 177Lu-FC705
Highest Development Status: Phase I/ Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: FutureChem
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 18, 2022